| Pfizer Inc (PFE) | |||
|---|---|---|---|
| 49.86 0.11 (0.22%) | 08-16 16:04 | ||
| Open: | 49.38 | Pre. Close: | 49.75 |
| High: | 50.18 | Low: | 49.36 |
| Volume: | 12,519,784 | Market Cap: | 279,832M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 50.227 - 50.47 | 50.47 - 50.68 |
| Low: | 48.774 - 49.057 | 49.057 - 49.301 |
| Close: | 49.438 - 49.875 | 49.875 - 50.252 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 59.48 One year: 61.73 |
| Support: | Support1: 47.81 Support2: 39.78 |
| Resistance: | Resistance1: 50.92 Resistance2: 52.85 |
| Pivot: | 49.98  |
| Moving Averages: | MA(5): 49.59  MA(20): 50.35 MA(100): 51.02 MA(250): 50.24 |
| MACD: | MACD(12,26): -0.47 Signal(12,26,9): -0.43 |
| %K %D: | %K(14,3): 43.16 %D(3): 33.79 |
| RSI: | RSI(14): 46.48 |
| 52-Week: | High: 61.71 Low: 40.94 Change(%): 3.1 |
| Average Vol(K): | 3-Month: 20385 10-Days: 18343 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PFE ] has closed above bottom band by 46.0%. Bollinger Bands are 43.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers—General | |
| Shares Out. (M) | 5610.00 |
| Shares Float (M) | 5610.00 |
| % Held by Insiders | 0.04 |
| % Held by Institutions | 69.13 |
| Shares Short (K) | 67350 |
| Shares Short Prior Month (K) | 76980 |
| Stock Financials | |
|---|---|
| EPS | 5.180 |
| Book Value (p.s.) | 14.740 |
| Profit Margin | 28.94 |
| Operating Margin | 37.61 |
| Return on Assets (ttm) | |
| Return on Equity (ttm) | |
| Qtrly Rev. Growth | 46.2 |
| Gross Profit (p.s.) | 9.025 |
| Sales Per Share | 18.053 |
| EBITDA (p.s.) | 7.676 |
| Qtrly Earnings Growth | 76.40 |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | |
| Stock Valuation | |
|---|---|
| PE Ratio | 9.63 |
| PEG Ratio | |
| Price to Book value | 3.38 |
| Price to Sales | 2.76 |
| Price to Cash Flow | |
| Stock Dividends | |
|---|---|
| Dividend | 0.400 |
| Dividend Yield | 0.01 |
| Dividend Growth | |
